Lung cancer is the most common cause of cancer deaths. Adenocarcinomas, a non-small cell lung cancer, account for about 40 percent of cancer diagnoses, but available treatments are limited. Researchers have identified a subtype of human adenocarcinoma. The research could help determine individuals who are at risk of developing lung tumors that may be amenable to a new therapy to inhibit their progression.